Therefore, HIF-1 could be a potential target for developing anticancer agents as it plays a key role in tumor cell adaptation to hypoxic environments by active transcription of genes that regulate processes like angiogenesis, cell proliferation, survival, metabolism of glucose, regulation of pH, and migration [85]. This evidence concerns the gene HIF1A and neoplasm.